;PMID: 7762971
;source_file_2994.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..44] = [t:0..44]
;1)sentence:[e:50..144] = [t:50..144]
;2)sentence:[e:145..154] = [t:145..154]
;3)section:[e:158..191] = [t:158..191]
;4)section:[e:195..311] = [t:195..311]
;5)sentence:[e:315..530] = [t:315..530]
;6)sentence:[e:531..690] = [t:531..690]
;7)sentence:[e:691..883] = [t:691..883]
;8)sentence:[e:884..1087] = [t:884..1087]
;9)sentence:[e:1088..1350] = [t:1088..1350]
;10)sentence:[e:1351..1464] = [t:1351..1464]
;11)section:[e:1468..1486] = [t:1468..1486]
;12)section:[e:1492..1498] = [t:1492..1498]
;13)section:[e:1504..1520] = [t:1504..1520]
;14)section:[e:1524..1568] = [t:1524..1568]

;section 0 Span:0..44
;Ann Clin Lab Sci.  1995 Jan-Feb;25(1):66-78.
(SEC
  (FRAG (NNP:[0..3] Ann) (NNP:[4..8] Clin) (NNP:[9..12] Lab) (NNP:[13..16] Sci)
        (.:[16..17] .) (CD:[19..23] 1995) (NNP:[24..28] Jan-)
        (CC:[28..35] Feb;25-LRB-) (CD:[35..36] 1) (-RRB-:[36..37] -RRB-)
        (::[37..38] :) (CD:[38..43] 66-78) (.:[43..44] .)))

;sentence 1 Span:50..144
;Immunohistology, cytogenetics, and molecular studies of small round cell
;tumors  of childhood.
;[106..129]:malignancy-type:"small round cell tumors"
;[134..143]:malignancy-developmental-state:"childhood"
(SENT
  (NP-HLN
    (NP
      (NP (NN:[50..65] Immunohistology))
      (,:[65..66] ,)
      (NP (NNS:[67..79] cytogenetics))
      (,:[79..80] ,) (CC:[81..84] and)
      (NP (JJ:[85..94] molecular) (NNS:[95..102] studies)))
    (PP (IN:[103..105] of)
      (NP
        (NP (JJ:[106..111] small) (JJ:[112..117] round) (NN:[118..122] cell)
            (NNS:[123..129] tumors))
        (PP (IN:[131..133] of)
          (NP (NN:[134..143] childhood)))))
    (.:[143..144] .)))

;sentence 2 Span:145..154
;A review.
(SENT
  (NP-HLN (DT:[145..146] A) (NN:[147..153] review) (.:[153..154] .)))

;section 3 Span:158..191
;Winters JL, Geil JD, O'Connor WN.
(SEC
  (FRAG (NNP:[158..165] Winters) (NNP:[166..168] JL) (,:[168..169] ,)
        (NNP:[170..174] Geil) (NNP:[175..177] JD) (,:[177..178] ,)
        (NNP:[179..187] O'Connor) (NNP:[188..190] WN) (.:[190..191] .)))

;section 4 Span:195..311
;Department of Pathology and Laboratory Medicine, College of Medicine,
;University  of Kentucky, Lexington 40536, USA.
(SEC
  (FRAG (NNP:[195..205] Department) (IN:[206..208] of)
        (NNP:[209..218] Pathology) (CC:[219..222] and)
        (NNP:[223..233] Laboratory) (NNP:[234..242] Medicine) (,:[242..243] ,)
        (NNP:[244..251] College) (IN:[252..254] of) (NNP:[255..263] Medicine)
        (,:[263..264] ,) (NNP:[265..275] University) (IN:[277..279] of)
        (NNP:[280..288] Kentucky) (,:[288..289] ,) (NNP:[290..299] Lexington)
        (CD:[300..305] 40536) (,:[305..306] ,) (NNP:[307..310] USA)
        (.:[310..311] .)))

;sentence 5 Span:315..530
;Malignancies of childhood include a well-defined spectrum of hematolymphoid, 
;organ specific (adrenal, kidney, liver), soft tissue, bone, and nervous
;system  (central and peripheral) neoplasms with variable biology.
;[331..340]:malignancy-developmental-state:"childhood"
;[376..390]...[498..507]:malignancy-type:"hematolymphoid"..."neoplasms"
;[409..416]...[498..507]:malignancy-type:"adrenal"..."neoplasms"
;[418..424]...[498..507]:malignancy-type:"kidney"..."neoplasms"
;[426..431]...[498..507]:malignancy-type:"liver"..."neoplasms"
;[434..445]...[498..507]:malignancy-type:"soft tissue"..."neoplasms"
;[447..451]...[498..507]:malignancy-type:"bone"..."neoplasms"
;[457..471]...[486..496]...[498..507]:malignancy-type:"nervous
;system"..."peripheral"..."neoplasms"
;[457..471]...[474..481]...[498..507]:malignancy-type:"nervous
;system"..."central"..."neoplasms"
(SENT
  (S
    (NP-SBJ
      (NP (NNS:[315..327] Malignancies))
      (PP (IN:[328..330] of)
        (NP (NN:[331..340] childhood))))
    (VP (VBP:[341..348] include)
      (NP
        (NP (DT:[349..350] a)
          (ADJP (RB:[351..355] well) (HYPH:[355..356] -)
                (VBN:[356..363] defined))
          (NN:[364..372] spectrum))
        (PP (IN:[373..375] of)
          (NP
            (NP
              (NP (JJ:[376..390] hematolymphoid)
                (NML-1 (-NONE-:[390..390] *P*)))
              (,:[390..391] ,)
              (NP (NN:[393..398] organ) (JJ:[399..407] specific)
                (NML-1 (-NONE-:[407..407] *P*))
                (PRN (-LRB-:[408..409] -LRB-)
                  (NP (JJ:[409..416] adrenal) (,:[416..417] ,)
                      (NN:[418..424] kidney) (,:[424..425] ,)
                      (NN:[426..431] liver))
                  (-RRB-:[431..432] -RRB-)))
              (,:[432..433] ,)
              (NP
                (NML (JJ:[434..438] soft) (NN:[439..445] tissue))
                (NML-1 (-NONE-:[445..445] *P*)))
              (,:[445..446] ,)
              (NP (NN:[447..451] bone)
                (NML-1 (-NONE-:[451..451] *P*)))
              (,:[451..452] ,) (CC:[453..456] and)
              (NP (JJ:[457..464] nervous) (NN:[465..471] system)
                (PRN (-LRB-:[473..474] -LRB-)
                  (ADJP (JJ:[474..481] central) (CC:[482..485] and)
                        (JJ:[486..496] peripheral))
                  (-RRB-:[496..497] -RRB-))
                (NML-1 (NNS:[498..507] neoplasms))))
            (PP (IN:[508..512] with)
              (NP (JJ:[513..521] variable) (NN:[522..529] biology)))))))
    (.:[529..530] .)))

;sentence 6 Span:531..690
;Small round cell  neoplasms, a subset of childhood malignancies, are
;histologically similar but  differ markedly in their histogenesis, therapy,
;and prognosis.
;[531..558]:malignancy-type:"Small round cell  neoplasms"
;[572..581]:malignancy-developmental-state:"childhood"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[531..536] Small) (JJ:[537..542] round) (NN:[543..547] cell)
          (NNS:[549..558] neoplasms))
      (,:[558..559] ,)
      (NP
        (NP (DT:[560..561] a) (NN:[562..568] subset))
        (PP (IN:[569..571] of)
          (NP (NN:[572..581] childhood) (NNS:[582..594] malignancies)))))
    (,:[594..595] ,)
    (VP
      (VP (VBP:[596..599] are)
        (ADJP-PRD (RB:[600..614] histologically) (JJ:[615..622] similar)))
      (CC:[623..626] but)
      (VP (VBP:[628..634] differ)
        (ADVP (RB:[635..643] markedly))
        (PP (IN:[644..646] in)
          (NP
            (NP (PRP$:[647..652] their) (NN:[653..665] histogenesis))
            (,:[665..666] ,)
            (NP (NN:[667..674] therapy))
            (,:[674..675] ,) (CC:[676..679] and)
            (NP (NN:[680..689] prognosis))))))
    (.:[689..690] .)))

;sentence 7 Span:691..883
;Traditionally,  clinical information and light microscopy, with the aid of
;histochemistry and  ultrastructural evaluation, establish a diagnosis or at
;least narrow the  differential diagnosis.
(SENT
  (S
    (ADVP (RB:[691..704] Traditionally))
    (,:[704..705] ,)
    (NP-SBJ
      (NP (JJ:[707..715] clinical) (NN:[716..727] information))
      (CC:[728..731] and)
      (NP (NN:[732..737] light) (NN:[738..748] microscopy)))
    (,:[748..749] ,)
    (PP (IN:[750..754] with)
      (NP
        (NP (DT:[755..758] the) (NN:[759..762] aid))
        (PP (IN:[763..765] of)
          (NP
            (NP (NN:[766..780] histochemistry))
            (CC:[781..784] and)
            (NP (JJ:[786..801] ultrastructural) (NN:[802..812] evaluation))))))
    (,:[812..813] ,)
    (VP
      (VP (VBP:[814..823] establish)
        (NP (DT:[824..825] a) (NN:[826..835] diagnosis)))
      (CC:[836..838] or)
      (VP
        (ADVP (IN:[839..841] at) (JJS:[842..847] least))
        (VBP:[848..854] narrow)
        (NP (DT:[855..858] the) (JJ:[860..872] differential)
            (NN:[873..882] diagnosis))))
    (.:[882..883] .)))

;sentence 8 Span:884..1087
;Additionally, immunohistology, cytogenetics, and  molecular studies have
;become important in diagnosis and in defining  phenotype/genotype, patient
;treatment modalities, and prognosis in specific  cases.
(SENT
  (S
    (ADVP (RB:[884..896] Additionally))
    (,:[896..897] ,)
    (NP-SBJ
      (NP (NN:[898..913] immunohistology))
      (,:[913..914] ,)
      (NP (NNS:[915..927] cytogenetics))
      (,:[927..928] ,) (CC:[929..932] and)
      (NP (JJ:[934..943] molecular) (NNS:[944..951] studies)))
    (VP (VBP:[952..956] have)
      (VP (VBN:[957..963] become)
        (ADJP-PRD (JJ:[964..973] important))
        (PP
          (PP (IN:[974..976] in)
            (NP (NN:[977..986] diagnosis)))
          (CC:[987..990] and)
          (PP (IN:[991..993] in)
            (S-NOM
              (NP-SBJ (-NONE-:[993..993] *))
              (VP (VBG:[994..1002] defining)
                (NP
                  (NP (NN:[1004..1013] phenotype) (SYM:[1013..1014] /)
                      (NN:[1014..1022] genotype))
                  (,:[1022..1023] ,)
                  (NP (NN:[1024..1031] patient) (NN:[1032..1041] treatment)
                      (NNS:[1042..1052] modalities))
                  (,:[1052..1053] ,) (CC:[1054..1057] and)
                  (NP
                    (NP (NN:[1058..1067] prognosis))
                    (PP (IN:[1068..1070] in)
                      (NP (JJ:[1071..1079] specific) (NNS:[1081..1086] cases)))))))))))
    (.:[1086..1087] .)))

;sentence 9 Span:1088..1350
;The 11;22 chromosomal translocation typifies Ewing's sarcoma, primitive 
;neuroectodermal tumor, and Askin's tumor, as does the resultant chimeric 
;transcript, while expression and amplification of N-myc oncogene are
;predictive  of the prognosis in neuroblastoma.
;[1092..1094]:variation-state-original:"11"
;[1095..1097]:variation-state-altered:"22"
;[1110..1123]:variation-type:"translocation"
;[1133..1148]:malignancy-type:"Ewing's sarcoma"
;[1150..1182]:malignancy-type:"primitive  neuroectodermal tumor"
;[1188..1201]:malignancy-type:"Askin's tumor"
;[1268..1281]:variation-type:"amplification"
;[1285..1290]:gene-rna:"N-myc"
;[1336..1349]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (NP-SBJ (DT:[1088..1091] The)
      (NML (CD:[1092..1094] 11) (::[1094..1095] ;) (CD:[1095..1097] 22))
      (JJ:[1098..1109] chromosomal) (NN:[1110..1123] translocation))
    (VP (VBZ:[1124..1132] typifies)
      (NP
        (NP
          (NP (NNP:[1133..1138] Ewing) (POS:[1138..1140] 's))
          (NN:[1141..1148] sarcoma))
        (,:[1148..1149] ,)
        (NP (JJ:[1150..1159] primitive) (JJ:[1161..1176] neuroectodermal)
            (NN:[1177..1182] tumor))
        (,:[1182..1183] ,) (CC:[1184..1187] and)
        (NP
          (NP (NNP:[1188..1193] Askin) (POS:[1193..1195] 's))
          (NN:[1196..1201] tumor)))
      (,:[1201..1202] ,)
      (SBAR-ADV (IN:[1203..1205] as)
        (SINV (VBZ:[1206..1210] does)
          (NP-SBJ (DT:[1211..1214] the) (JJ:[1215..1224] resultant)
                  (JJ:[1225..1233] chimeric) (NN:[1235..1245] transcript))
          (VP (-NONE-:[1245..1245] *?*))))
      (,:[1245..1246] ,)
      (SBAR-ADV (IN:[1247..1252] while)
        (S
          (NP-SBJ
            (NP (NN:[1253..1263] expression) (CC:[1264..1267] and)
                (NN:[1268..1281] amplification))
            (PP (IN:[1282..1284] of)
              (NP (NN:[1285..1290] N-myc) (NN:[1291..1299] oncogene))))
          (VP (VBP:[1300..1303] are)
            (ADJP-PRD (JJ:[1304..1314] predictive)
              (PP (IN:[1316..1318] of)
                (NP (DT:[1319..1322] the) (NN:[1323..1332] prognosis))))
            (PP (IN:[1333..1335] in)
              (NP (NN:[1336..1349] neuroblastoma)))))))
    (.:[1349..1350] .)))

;sentence 10 Span:1351..1464
;Furthermore, studies of genes and gene  products are elucidating mechanisms
;of oncogenesis and tumor progression.
(SENT
  (S
    (ADVP (RB:[1351..1362] Furthermore))
    (,:[1362..1363] ,)
    (NP-SBJ
      (NP (NNS:[1364..1371] studies))
      (PP (IN:[1372..1374] of)
        (NP
          (NP (NNS:[1375..1380] genes))
          (CC:[1381..1384] and)
          (NP (NN:[1385..1389] gene) (NNS:[1391..1399] products)))))
    (VP (VBP:[1400..1403] are)
      (VP (VBG:[1404..1415] elucidating)
        (NP (NNS:[1416..1426] mechanisms))
        (PP (IN:[1427..1429] of)
          (NP
            (NP (NN:[1430..1441] oncogenesis))
            (CC:[1442..1445] and)
            (NP (NN:[1446..1451] tumor) (NN:[1452..1463] progression))))))
    (.:[1463..1464] .)))

;section 11 Span:1468..1486
;Publication Types:
(SEC
  (FRAG (NNP:[1468..1479] Publication) (NNP:[1480..1485] Types)
        (::[1485..1486] :)))

;section 12 Span:1492..1498
;Review
(SEC
  (FRAG (NNP:[1492..1498] Review)))

;section 13 Span:1504..1520
;Review, Tutorial
(SEC
  (FRAG (NNP:[1504..1510] Review) (,:[1510..1511] ,) (NNP:[1512..1520] Tutorial)))

;section 14 Span:1524..1568
;PMID: 7762971 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1524..1528] PMID) (::[1528..1529] :) (CD:[1530..1537] 7762971)
        (NN:[1538..1539] -LSB-) (NNP:[1539..1545] PubMed) (::[1546..1547] -)
        (NN:[1548..1555] indexed) (IN:[1556..1559] for)
        (NNP:[1560..1568] MEDLINE-RSB-)))
